Project Grant HT94252510580
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $771,627 project grant to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct advanced biomedical research on tuning and strike targeting of glioblastoma. The 24-month award period runs from August 1, 2025 to July 31, 2027. As a leading academic medical center and recipient of significant federal research funding, Massachusetts General Hospital will...
The Defense Health Agency awarded Massachusetts General Hospital a $368,238 project grant under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2023 through August 31, 2026. The grant will fund research to determine if microbiome-derived cell fragments in the brain accelerate transition from traumatic brain injury to Alzheimer's disease or related dementias. As a leading academic medical center, Massachusetts General Hospital will leverage its expertise in...
The U.S. Defense Health Agency awarded a $1,626,932.00 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund the "Detection and Quantification of Early Motor...
The U.S. Defense Health Agency awarded a $888,632 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant, which runs from April 1, 2025 to March 31, 2027, supports research to decipher the role of maternal autoantibodies in inducing behavioral abnormalities in offspring following maternal Toll-like receptor 7 (TLR7) activation. The research aims to...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,234,505.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award supports research to cotarget the tumor microenvironment and revolutionize antibody-drug conjugate...
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
The federal Project Grant award of $1,949,901.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Salisbury Foundation For Research And Education, doing business as Hefner Ba Medical Center, on the relationship between blast exposure and cellular senescence in veterans. The award period runs from September 1, 2025 to August 31, 2029. The research aims to investigate the impact of blast exposure on hippocampal volume and...
The federal Project Grant award, identified as HT94252510088, is provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, totaling $1,618,114.00, supports research conducted by The General Hospital Corporation (doing business as Massachusetts General Hospital) to define the role of anti-nephrin antibodies in the recurrence of focal segmental glomerulosclerosis post transplantation. This 3-year research project, with a period of...
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,498,368 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 1, 2024 to July 31, 2027. The grant supports research to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, in order to optimize treatment of high-...
This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August...